Daniel Raynor, Director at ANI PHARMACEUTICALS INC (ANIP), sold 41,928 shares at $62.88 ($2.6M) on 2018-03-12, disclosed to the SEC on 2018-03-14.
Open-market sale of $2.6M ANIP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.88 | 7,928 | $499K | 19.1% |
| 2 | $62.88 | 7,928 | $499K | 19.1% |
| 3 | $61.81 | 14,000 | $865K | 33.1% |
| 4 | $62.59 | 4,117 | $258K | 9.9% |
| 5 | $62.59 | 4,117 | $258K | 9.9% |
| 6 | $62.02 | 1,919 |
| $119K |
| 4.5% |
| 7 | $62.02 | 1,919 | $119K | 4.5% |
| Total | $62.39 avg | 41,928 | $2.6M | 100% |
| Filing → |
| ANIP | SELL | 2014-03-18 | $716K | — | Filing → |
| ANIP | SELL | 2014-03-18 | $418K | — | Filing → |
| ANIP | SELL | 2014-03-14 | $715K | — | Filing → |